Effect of Gastrointestinal Adverse Events on Treatment Satisfaction in Semaglutide Treatment of Type 2 Diabetes von Jendle, J, Birkenfeld, AL, Silver, R, Uusinarkaus, K, Højbjerre, L, Thomsen, HF, Davies, M

Volltext

Improved treatment satisfaction in patients with type 2 diabetes treated with once‐weekly semaglutide in the SUSTAIN trials von Jendle, Johan, Birkenfeld, Andreas L., Polonsky, William H., Silver, Robert, Uusinarkaus, Kari, Hansen, Thomas, Håkan‐Bloch, Jonas, Tadayon, Sayeh, Davies, Melanie J.

Volltext

PDB54 - Effect of Gastrointestinal Adverse Events on Treatment Satisfaction in Semaglutide Treatment of Type 2 Diabetes von Jendle, J, Birkenfeld, AL, Silver, R, Uusinarkaus, K, Højbjerre, L, Thomsen, HF, Davies, M

Volltext

Méta-analyse des études SUSTAIN 1-5 : Perte de poids sous semaglutide dans le diabète de type 2 von Cariou, B., Marre, M., Davies, M., Lingvay, I., Lüdemann, J., Uusinarkaus, K., Woo, V., Thomsen, H.F., Wijayasinghe, N., Bouzidi, A.

Volltext